US halts University's research funding after asthma death

22 July 2001

The US federal Office of Human Research Protection has suspended allfederally-funded research on human subjects at Johns Hopkins University, after a healthy volunteer, 24-year-old Ellen Roche, died during an asthma experiment.

Following Ms Roche's death on June 2, probably from inhaling the drug hexamethomium and for which the University acknowledged full responsibility, it suspended all human research work by the doctor in charge, Alkis Togias. No further disciplinary action has been taken against him.

The University regularly receives more federal research funding than any other US medical school, and last year's total was $301 million. In the wake of Ms Roche's death, it said it would be increasing the supervision of all studies, and an external investigation would be conducted into the study in which Ms Roche died.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight